MX2021004826A - Formulacion de emulsion y metodo para preparar la misma. - Google Patents
Formulacion de emulsion y metodo para preparar la misma.Info
- Publication number
- MX2021004826A MX2021004826A MX2021004826A MX2021004826A MX2021004826A MX 2021004826 A MX2021004826 A MX 2021004826A MX 2021004826 A MX2021004826 A MX 2021004826A MX 2021004826 A MX2021004826 A MX 2021004826A MX 2021004826 A MX2021004826 A MX 2021004826A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- emulsion preparation
- types
- emulsion
- ctl epitope
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 7
- 239000000839 emulsion Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000007762 w/o emulsion Substances 0.000 abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/65—Mixers with shaking, oscillating, or vibrating mechanisms the materials to be mixed being directly submitted to a pulsating movement, e.g. by means of an oscillating piston or air column
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se proporciona una formulación de emulsión tipo agua en aceite (w/o) que contiene de manera estable tres tipos de péptidos enlazados a cuatro epítopos de CTL. También se proporciona un método para preparar eficazmente la preparación de emulsión w/o que contiene tres tipos de péptidos enlazados a cuatro epítopos de CTL. La presente invención proporciona una formulación de emulsión w/o que contiene de forma estable tres tipos de péptidos enlazados a cuatro epítopos de CTL y también proporciona un método para preparar eficazmente la formulación de emulsión w/o. También se proporcionan un método y un dispositivo mejorados para preparar la formulación.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018207779 | 2018-11-02 | ||
| PCT/JP2019/043023 WO2020091040A1 (ja) | 2018-11-02 | 2019-11-01 | エマルジョン製剤及びその調製方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021004826A true MX2021004826A (es) | 2021-06-15 |
Family
ID=70463271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021004826A MX2021004826A (es) | 2018-11-02 | 2019-11-01 | Formulacion de emulsion y metodo para preparar la misma. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210401745A1 (es) |
| EP (1) | EP3878463A4 (es) |
| JP (1) | JP7508371B2 (es) |
| KR (1) | KR20210084584A (es) |
| CN (1) | CN112955173A (es) |
| AU (1) | AU2019369845A1 (es) |
| BR (1) | BR112021008172A2 (es) |
| CA (1) | CA3118417A1 (es) |
| MA (1) | MA54182A (es) |
| MX (1) | MX2021004826A (es) |
| PH (1) | PH12021550993A1 (es) |
| SG (1) | SG11202104416YA (es) |
| TW (1) | TW202033181A (es) |
| WO (1) | WO2020091040A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2312511A1 (fr) | 1975-05-27 | 1976-12-24 | Naphtachimie Sa | Polymerisation a sec des olefines dans des reacteurs en serie |
| JPWO2007083763A1 (ja) | 2006-01-23 | 2009-06-11 | 株式会社グリーンペプタイド | 生理活性ペプチドのエマルション製剤の調製方法、および当該製剤を調製するためのキット |
| US9073021B2 (en) | 2008-09-05 | 2015-07-07 | Oncotherapy Science, Inc. | Device and method for automatically preparing emulsion drug |
| PT3061771T (pt) * | 2013-10-21 | 2020-05-06 | Taiho Pharmaceutical Co Ltd | Novo péptido unido a quatro epitopos ctl |
| JP2018207779A (ja) | 2018-09-20 | 2018-12-27 | 株式会社ニコン | 振動アクチュエータ、レンズ鏡筒及びカメラ |
-
2019
- 2019-11-01 MA MA054182A patent/MA54182A/fr unknown
- 2019-11-01 CN CN201980072464.4A patent/CN112955173A/zh active Pending
- 2019-11-01 EP EP19878345.8A patent/EP3878463A4/en active Pending
- 2019-11-01 CA CA3118417A patent/CA3118417A1/en active Pending
- 2019-11-01 US US17/290,650 patent/US20210401745A1/en active Pending
- 2019-11-01 AU AU2019369845A patent/AU2019369845A1/en active Pending
- 2019-11-01 WO PCT/JP2019/043023 patent/WO2020091040A1/ja unknown
- 2019-11-01 JP JP2020554980A patent/JP7508371B2/ja active Active
- 2019-11-01 SG SG11202104416YA patent/SG11202104416YA/en unknown
- 2019-11-01 MX MX2021004826A patent/MX2021004826A/es unknown
- 2019-11-01 BR BR112021008172-0A patent/BR112021008172A2/pt unknown
- 2019-11-01 TW TW108139740A patent/TW202033181A/zh unknown
- 2019-11-01 KR KR1020217016364A patent/KR20210084584A/ko not_active Application Discontinuation
-
2021
- 2021-04-30 PH PH12021550993A patent/PH12021550993A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN112955173A (zh) | 2021-06-11 |
| EP3878463A4 (en) | 2022-12-07 |
| JPWO2020091040A1 (ja) | 2021-09-30 |
| PH12021550993A1 (en) | 2021-10-04 |
| JP7508371B2 (ja) | 2024-07-01 |
| MA54182A (fr) | 2021-09-15 |
| TW202033181A (zh) | 2020-09-16 |
| AU2019369845A1 (en) | 2021-05-27 |
| WO2020091040A1 (ja) | 2020-05-07 |
| CA3118417A1 (en) | 2020-05-07 |
| BR112021008172A2 (pt) | 2021-08-17 |
| KR20210084584A (ko) | 2021-07-07 |
| SG11202104416YA (en) | 2021-05-28 |
| EP3878463A1 (en) | 2021-09-15 |
| US20210401745A1 (en) | 2021-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022013526A (es) | Degradadores de proteinas y usos de los mismos. | |
| SG10201805290YA (en) | System and method for evaluation of used components | |
| MY202410A (en) | Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring | |
| PH12017502165A1 (en) | Anti-tau antibodies and methods of use | |
| CR20230163A (es) | ANTICUERPOS ANTITAU Y MÉTODOS DE USO (Divisional 2019-0271) | |
| MA40938A (fr) | Anticorps anti-cd79b et méthodes d'utilisation desdits anticorps | |
| MX2017000419A (es) | Anticuerpos anti-pd-l1 y sus usos de diagnóstico. | |
| MX2017006094A (es) | Anticuerpos anti-interleucina-33 y sus usos. | |
| EA201691993A1 (ru) | Вакцина к вирусу эпидемической диареи свиней | |
| MX2019001471A (es) | Anticuerpos anti-siglec-7 para el tratamiento del cancer. | |
| MX2019006330A (es) | Anticuerpos anti-tau y metodos de uso. | |
| CR20200404A (es) | Anticuerpos anti-klk5 y métodos de uso | |
| MX2018010971A (es) | Compuestos y métodos para modular la tirosina cinasa de bruton. | |
| MX2021014439A (es) | Metodos y aparatos para microorganoesferas derivadas de pacientes. | |
| CO2021000092A2 (es) | Anticuerpos que comprenden un polipéptido insertado en la región 3 del marco | |
| MX2017012284A (es) | Nuevos metodos para la seleccion de epitopos. | |
| MX2022003212A (es) | Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecificos anti-klk5/klk7 y metodos de uso. | |
| IL277838A (en) | A method for separating a solid-phase bound peptide from the solid phase | |
| EA202091095A1 (ru) | Пероральная доставка пептидных аналогов glp-1 | |
| CR20200642A (es) | Proteínas inmunodominantes y fragmentos en esclerosis múltiples | |
| MX2021006102A (es) | Suministro mejorado de agentes grandes. | |
| MX2020014205A (es) | Uso de cromatografia de interaccion hidrofobica multiple para preparar un polipeptido a partir de una mezcla. | |
| MX2021004826A (es) | Formulacion de emulsion y metodo para preparar la misma. | |
| MX2022006784A (es) | Formulaciones de anticuerpos anti-pd-l1. | |
| MX2019013211A (es) | Proteinas de union al antigeno anti-jagged1. |